CREDOPHAR

Active Private limited companyfounded 2012active for 14 yearsKortrijksesteenweg 1091, 9051 GhentKBO/BCE: BE 0849.730.193 subsidiary of Ceres Pharma

Part of the group Ceres Invest 28 companies in 10 countries

See the group

CREDOPHAR

Follow Report Compare

Holdings

own 2025 accounts, the bar shows equity in euros

This companyCREDOPHAR1 holding, 1 country 2025 accounts

Belgium 1 Equity Result

BE Labophar €2.5m result -€375,714

Source: list of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.

Part of the group Ceres Invest Group, risk and exposure

Parent

Ceres Pharma

0641.953.324 · 100% of the shares · equity -€1.6m · loss €14.4m (2025)

Checked score 53

At the same address

Kortrijksesteenweg 1091, 9051 Ghent · 22 other companies

Ceres Pharma registered office since 28-10-2015 · founded in 2015 · negative equity (2025) · group Ceres Invest	37 FTE (2025) 0641.953.324
What’s Cooking Belgium registered office since 06-11-2006 · founded in 2006 · group What's Cooking Group	39 FTE (2025) 0884.649.304
What's Cooking Group registered office since 19-03-1981 · founded in 1981	48 FTE (2025) 0421.364.139
Ceres Invest registered office since 13-10-2021 · founded in 2021	turnover €2.5m (2025) 0775.683.264
Ceres Pharmaceuticals registered office since 27-05-2021 · founded in 1970 · group Ceres Invest	18 FTE (2025) 0407.326.754
Labophar registered office since 30-11-2015 · founded in 2015 · group Ceres Invest	turnover €406,703 (2025) 0643.723.177
MD Pharma registered office since 16-12-2016 · founded in 2016 · group Ceres Invest	total assets €2.7m (2025) 0667.779.672
b+pharma Belgium registered office since 02-08-2001 · founded in 2001 · group Ceres Invest	total assets €2.4m (2025) 0474.817.869
2PHARMA HOLDING registered office since 22-12-2015 · founded in 2015 · group Ceres Invest	total assets €1.9m (2025) 0644.751.377
CONESSENCE INTERIM MANAGEMENT registered office since 26-12-2019 · founded in 2019	total assets €1.7m (2025) 0740.472.066

and 12 more

Holdings and subsidiaries

1 holding · 3 subsidiaries, including indirect ones

Share, source and own figures per holding (1)

Labopharsubsidiary
Equity €2.5m Loss of €375,714 in 2025 (loss of €417,897 in 2024) Checked score 85
Sourceown accounts 2025 accounts Labophar 2025

100%

All subsidiaries, including indirect ones 3

CREDOPHAR or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.

Labophar 100%2 subsidiaries
- b+pharma Belgium 100%
- DGPharma 100%

Holdings through the years 2022 to 2025

Holdings through the years
Name	2022	2023	2024	2025
Labophar 2022 to 2025: 100%	100%

Source: list of holdings in its own accounts

Board mandates elsewhere

1 board mandate

Board mandates of CREDOPHARCREDOPHAR sits on their board1

b+pharma Belgium

Director

Founded in 2001 · total assets €2.4m (2025) · group Ceres Invest

Acquisitions and mergers

1 transaction

Demerger with:Pharma Boulevard

demerger · Gazette deed of 12-05-2021

Connections & network

2 current directors

Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet